![Rolf Lood](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 7 438 $ al 31/05/2026
Rolf Lood is currently Vice President-Research & Development at Genovis AB since 2017.
Dr. Lood is also an Associate Professor at the University of Lund.
Dr. Lood holds a doctorate degree from the University of Lund.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENOVIS AB 0,01 % | 31/12/2024 | 3.400 ( 0,01 % ) | 7 438 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENOVIS AB | Director Técnico/Científico/I+D | 01/01/2017 |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Genovis AB
 Genovis AB Medical SpecialtiesHealth Technology Produces and develops medical device and pharmaceutical products | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
